AAAAAA

   
Results: 1-18 |
Results: 18
PRAMLINTIDE, A SYNTHETIC ANALOG OF HUMAN AMYLIN, IMPROVES THE METABOLIC PROFILE OF PATIENTS WITH TYPE-2 DIABETES USING INSULIN
Authors: THOMPSON RG PEARSON L SCHOENFELD SL KOLTERMAN OG
Citation: Rg. Thompson et al., PRAMLINTIDE, A SYNTHETIC ANALOG OF HUMAN AMYLIN, IMPROVES THE METABOLIC PROFILE OF PATIENTS WITH TYPE-2 DIABETES USING INSULIN, Diabetes care, 21(6), 1998, pp. 987-993
THE HUMAN AMYLIN ANALOG PRAMLINTIDE SUPPRESSED GLUCAGON-SECRETION IN PATIENTS WITH TYPE-2 DIABETES
Authors: FINEMAN MS ORGAN K KOLTERMAN OG
Citation: Ms. Fineman et al., THE HUMAN AMYLIN ANALOG PRAMLINTIDE SUPPRESSED GLUCAGON-SECRETION IN PATIENTS WITH TYPE-2 DIABETES, Diabetologia, 41, 1998, pp. 653-653
PRAMLINTIDE - A HUMAN AMYLIN ANALOG REDUCED POSTPRANDIAL PLASMA-GLUCOSE, INSULIN, AND C-PEPTIDE CONCENTRATIONS IN PATIENTS WITH TYPE-2 DIABETES
Authors: THOMPSON RG GOTTLIEB A ORGAN K KODA J KISICKI J KOLTERMAN OG
Citation: Rg. Thompson et al., PRAMLINTIDE - A HUMAN AMYLIN ANALOG REDUCED POSTPRANDIAL PLASMA-GLUCOSE, INSULIN, AND C-PEPTIDE CONCENTRATIONS IN PATIENTS WITH TYPE-2 DIABETES, Diabetic medicine, 14(7), 1997, pp. 547-555
AMYLIN AND GLYCEMIC REGULATION - A POSSIBLE ROLE FOR THE HUMAN AMYLINANALOG PRAMLINTIDE
Authors: KOLTERMAN OG
Citation: Og. Kolterman, AMYLIN AND GLYCEMIC REGULATION - A POSSIBLE ROLE FOR THE HUMAN AMYLINANALOG PRAMLINTIDE, Diabetic medicine, 14(6), 1997, pp. 35-38
EFFECTS OF 4 WEEKS ADMINISTRATION OF PRAMLINTIDE, A HUMAN AMYLIN ANALOG, ON GLYCEMIA CONTROL IN PATIENTS WITH IDDM - EFFECTS ON PLASMA-GLUCOSE PROFILES AND SERUM FRUCTOSAMINE CONCENTRATIONS
Authors: THOMPSON RG PEARSON L KOLTERMAN OG
Citation: Rg. Thompson et al., EFFECTS OF 4 WEEKS ADMINISTRATION OF PRAMLINTIDE, A HUMAN AMYLIN ANALOG, ON GLYCEMIA CONTROL IN PATIENTS WITH IDDM - EFFECTS ON PLASMA-GLUCOSE PROFILES AND SERUM FRUCTOSAMINE CONCENTRATIONS, Diabetologia, 40(11), 1997, pp. 1278-1285
THE HUMAN AMYLIN ANALOG PRAMLINTIDE INHIBITED GLUCAGON-SECRETION IN TYPE-I DIABETIC SUBJECTS
Authors: FINEMAN MS KOLTERMAN OG THOMPSON RG
Citation: Ms. Fineman et al., THE HUMAN AMYLIN ANALOG PRAMLINTIDE INHIBITED GLUCAGON-SECRETION IN TYPE-I DIABETIC SUBJECTS, Diabetologia, 40, 1997, pp. 1398-1398
SELF-CARE BEHAVIORS IN INSULIN-DEPENDENT DIABETES - EVALUATIVE TOOLS AND THEIR ASSOCIATIONS WITH GLYCEMIC CONTROL
Authors: HANSON CL DEGUIRE MJ SCHINKEL AM KOLTERMAN OG GOODMAN JP BUCKINGHAM BA
Citation: Cl. Hanson et al., SELF-CARE BEHAVIORS IN INSULIN-DEPENDENT DIABETES - EVALUATIVE TOOLS AND THEIR ASSOCIATIONS WITH GLYCEMIC CONTROL, Journal of pediatric psychology, 21(4), 1996, pp. 467-482
PHARMACOKINETICS AND PHARMACODYNAMICS OF AC137 (25,28,29-TRIPRO-AMYLIN, HUMAN) AFTER INTRAVENOUS BOLUS AND INFUSION DOSES IN PATIENTS WITH INSULIN-DEPENDENT DIABETES
Authors: COLBURN WA GOTTLIEB AB KODA J KOLTERMAN OG
Citation: Wa. Colburn et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF AC137 (25,28,29-TRIPRO-AMYLIN, HUMAN) AFTER INTRAVENOUS BOLUS AND INFUSION DOSES IN PATIENTS WITH INSULIN-DEPENDENT DIABETES, Journal of clinical pharmacology, 36(1), 1996, pp. 13-24
EFFECT OF 14 DAYS SUBCUTANEOUS ADMINISTRATION OF THE HUMAN AMYLIN ANALOG, PRAMLINTIDE (AC137), ON AN INTRAVENOUS INSULIN CHALLENGE AND RESPONSE TO A STANDARD LIQUID MEAL IN PATIENTS WITH IDDM
Authors: KOLTERMAN OG SCHWARTZ S CORDER C LEVY B KLAFF L PETERSON J GOTTLIEB A
Citation: Og. Kolterman et al., EFFECT OF 14 DAYS SUBCUTANEOUS ADMINISTRATION OF THE HUMAN AMYLIN ANALOG, PRAMLINTIDE (AC137), ON AN INTRAVENOUS INSULIN CHALLENGE AND RESPONSE TO A STANDARD LIQUID MEAL IN PATIENTS WITH IDDM, Diabetologia, 39(4), 1996, pp. 492-499
PHARMACOKINETICS OF PRAMLINTIDE AND FREE-INSULIN FOLLOWING COMBINED OR SEPARATE INJECTIONS IN PATIENTS WITH TYPE-I DIABETES
Authors: REDALIEU E THOMPSON RG DEAN E PETRELLA E MUSUNURI S GOTTLIEB A KOLTERMAN OG
Citation: E. Redalieu et al., PHARMACOKINETICS OF PRAMLINTIDE AND FREE-INSULIN FOLLOWING COMBINED OR SEPARATE INJECTIONS IN PATIENTS WITH TYPE-I DIABETES, Diabetes, 45, 1996, pp. 808-808
REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA IN SUBJECTS WITH IDDM BY INTRAVENOUS-INFUSION OF AC137, A HUMAN AMYLIN ANALOG
Authors: KOLTERMAN OG GOTTLIEB A MOYSES C COLBURN W
Citation: Og. Kolterman et al., REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA IN SUBJECTS WITH IDDM BY INTRAVENOUS-INFUSION OF AC137, A HUMAN AMYLIN ANALOG, Diabetes care, 18(8), 1995, pp. 1179-1182
EMPIRICAL VALIDATION FOR A FAMILY-CENTERED MODEL OF CARE
Authors: HANSON CL DEGUIRE MJ SCHINKEL AM KOLTERMAN OG
Citation: Cl. Hanson et al., EMPIRICAL VALIDATION FOR A FAMILY-CENTERED MODEL OF CARE, Diabetes care, 18(10), 1995, pp. 1347-1356
LOW-CARBOHYDRATE DIET ALTERS INTRACELLULAR GLUCOSE-METABOLISM BUT NOTOVERALL GLUCOSE DISPOSAL IN EXERCISE-TRAINED SUBJECTS
Authors: CUTLER DL GRAY CG PARK SW HICKMAN MG BELL JM KOLTERMAN OG
Citation: Dl. Cutler et al., LOW-CARBOHYDRATE DIET ALTERS INTRACELLULAR GLUCOSE-METABOLISM BUT NOTOVERALL GLUCOSE DISPOSAL IN EXERCISE-TRAINED SUBJECTS, Metabolism, clinical and experimental, 44(10), 1995, pp. 1264-1270
REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA IN PATIENTS WITH TYPE-II DIABETES BY THE HUMAN AMYLIN ANALOG-AC137
Authors: KOLTERMAN OG GOTTLIEB AB ORGAN KA THOMPSON RG
Citation: Og. Kolterman et al., REDUCTION OF POSTPRANDIAL HYPERGLYCEMIA IN PATIENTS WITH TYPE-II DIABETES BY THE HUMAN AMYLIN ANALOG-AC137, Diabetologia, 38, 1995, pp. 193-193
THE HUMAN AMYLIN ANALOG (AC137) REDUCES GLUCOSE FOLLOWING SUSTACAL(R)IN PATIENTS WITH TYPE-II DIABETES
Authors: THOMPSON RG GOTTLIEB AB ORGAN K KOLTERMAN OG
Citation: Rg. Thompson et al., THE HUMAN AMYLIN ANALOG (AC137) REDUCES GLUCOSE FOLLOWING SUSTACAL(R)IN PATIENTS WITH TYPE-II DIABETES, Diabetes, 44, 1995, pp. 127-127
24-HOUR PLASMA AMYLIN PROFILES ARE ELEVATED IN IGT SUBJECTS VS NORMALCONTROLS
Authors: KODA JE FINEMAN MS KOLTERMAN OG CARO JF
Citation: Je. Koda et al., 24-HOUR PLASMA AMYLIN PROFILES ARE ELEVATED IN IGT SUBJECTS VS NORMALCONTROLS, Diabetes, 44, 1995, pp. 238-238
HUMAN AMYLIN INCREASES PLASMA-RENIN IN MAN - A POSSIBLE LINK BETWEEN HYPERTENSION AND INSULIN-RESISTANCE
Authors: MCNALLY PG PHILLIPS PA JOHNSTON CI KOLTERMAN OG COOPER ME
Citation: Pg. Mcnally et al., HUMAN AMYLIN INCREASES PLASMA-RENIN IN MAN - A POSSIBLE LINK BETWEEN HYPERTENSION AND INSULIN-RESISTANCE, Diabetologia, 37, 1994, pp. 10000046-10000046
ADMINISTRATION OF TRIPRO-AMYLIN REDUCES POSTPRANDIAL HYPERGLYCEMIA INSUBJECTS WITH JUVENILE-ONSET DIABETES
Authors: KOLTERMAN OG GOTTLIEB AB MOYSES CJ
Citation: Og. Kolterman et al., ADMINISTRATION OF TRIPRO-AMYLIN REDUCES POSTPRANDIAL HYPERGLYCEMIA INSUBJECTS WITH JUVENILE-ONSET DIABETES, Diabetologia, 37, 1994, pp. 10000072-10000072
Risultati: 1-18 |